Increased levels of interleukin-12 in Plasmodium falciparum malaria: Correlation with the severity of disease

Parasite Immunology

Volumn 24, Issue 7, 2002, Pages 387-389

  Malaguarnera, Lucia ^a   Imbesi, Rosa Maria ^a   Pignatelli, Salvatore ^b   Simporè, Jacques ^b   Malaguarnera, Mariano ^a   Musumeci, Salvatore ^c,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b Medical Center Saint Camille   (Burkina Faso)

^c UNIVERSITY OF SASSARI   (Italy)

^d Department of Pediatrics ^*  (Italy)

Author keywords

IL 12; Macrophage activation; Malaria

Indexed keywords

INTERLEUKIN 12;

AFRICA; ARTICLE; CELLULAR IMMUNITY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INTERLEUKIN-12; MACROPHAGE ACTIVATION; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; SEVERITY OF ILLNESS INDEX;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0036417273     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3024.2002.00478.x     Document Type: Article

References (17)

1. World Health Organization. World malaria situation in 1994. Weekly Epidemiol Rec 1997; 72: 269-276.
2. Miller LH, Good MF, Milon G. Malaria pathogenesis. Science 1994; 264: 1878-1883.
3. Sherry BA, Alava G, Tracey KJ, Martiney J, Cerami A, Slater AF. Malaria specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP1α and MIP-1β) in vitro, and altered thermoregulation in vivo. J Inflamm 1995; 45: 85-96.
4. Taramelli D, Basilico N, Pagani E et al. The heme moiety of malaria pigment (β-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-α production by lipo polysaccharide-stimulated macrophages. Exp Parasitol 1995; 81: 501-511.
5. + T cells in the plasmodium yoelii model. J Immunol 1999; 163: 884-892.
6. Crutcher JM, Stevenson M, Sedegah M, Hoffman SL. Interleukin 12 and malaria. Res Immunol 1995; 146: 552-559.
7. Trinchieri G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistence and antigen-specific adaptative immunity. Ann Rev Immunol 1995; 12: 251-276.
8. O'Garra A, Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 2000; 10: 542-550.
9. Philips RE, Pasvol G. Anemia of plasmodium falciparum malaria. Baillieres Clin Haematol 1992; 5: 315-330.
10. Lee SH, Looareesuwan S, Chan J et al. Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia. Thromb Haemost 1997; 77: 289-293.
11. Schwarzer EF, Turrini F, Ulliers G, Giribaldi HG, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum infected erythrocytes or isolated malarial pigment. J Exp Med 1992; 173: 1033-1041.
12. Scholfiewd L, Hackett F. Signal transduction in host cells by glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med 1993; 177: 145-153.
13. Mohan K, Sam H, Stevenson MM. Therapy with a combination of low doses of interleukin-12 and cloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to re-infection. Infect Immun 1999; 67: 513-519.
14. Winkler S, Willheim M, Baier K et al. Frequency of cytokine producing T cells in patient of different age groups with Plasmodium falciparum malaria. J Infect Dis 1999; 179: 209-216.
15. Trinchieri G. IL-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14: 335-338.
16. Luty AJF, Perkins D, Lell B et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Imm 2000; 68: 3909-3915.
17. Perkins DJ, Weinberg JB, Kremsner PG. Reduced interleukin-12 and transforming growth factor-beta 1 in severe childhood malaria: Relationship of cytokine balance with disease severity. J Infect Dis 2000; 182: 988-992.